Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/30153
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHOUBEN, Evelien-
dc.contributor.authorHELLINGS, Niels-
dc.contributor.authorBROUX, Bieke-
dc.date.accessioned2019-12-16T12:50:31Z-
dc.date.available2019-12-16T12:50:31Z-
dc.date.issued2019-
dc.identifier.citationFRONTIERS IN IMMUNOLOGY, 10 (Art N° 1165)-
dc.identifier.urihttp://hdl.handle.net/1942/30153-
dc.description.abstractFor a long time, the central nervous system (CNS) was believed to be an immune privileged organ. In the last decades, it became apparent that the immune system interacts with the CNS not only in pathological, but also in homeostatic situations. It is now clear that immune cells infiltrate the healthy CNS as part of immune surveillance and that immune cells communicate through cytokines with CNS resident cells. In pathological conditions, an enhanced infiltration of immune cells takes place to fight the pathogen. A well-known family of cytokines is the interleukin (IL)-6 cytokine family. All members are important in cell communication and cell signaling in the immune system. One of these members is oncostatin M (OSM), for which the receptor is expressed on several cells of the CNS. However, the biological function of OSM in the CNS is not studied in detail. Here, we briefly describe the general aspects related to OSM biology, including signaling and receptor binding. Thereafter, the current understanding of OSM during CNS homeostasis and pathology is summarized.-
dc.description.sponsorshipThis work was financially supported by the Research Foundation of Flanders (FWO Vlaanderen, 1106817N). Figure 1 was adapted from smart servier medical art (https://smart.servier.com/).-
dc.language.isoen-
dc.publisherFRONTIERS MEDIA SA-
dc.rights© 2019 Houben, Hellings and Broux. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.-
dc.subject.otherOncostatin M (OSM)-
dc.subject.othercentral nervous system-
dc.subject.othercell biology-
dc.subject.otherhomeostasis-
dc.subject.otherpathology-
dc.titleOncostatin M, an Underestimated Player in the Central Nervous System-
dc.typeJournal Contribution-
dc.identifier.volume10-
local.format.pages8-
local.bibliographicCitation.jcatA1-
dc.description.notes[Houben, Evelien; Hellings, Niels; Broux, Bieke] Hasselt Univ, Biomed Res Inst, Dept Immunol, Diepenbeek, Belgium.-
local.publisher.placeLAUSANNE-
local.type.refereedRefereed-
local.type.specifiedReview-
local.bibliographicCitation.artnr1165-
dc.identifier.doi10.3389/fimmu.2019.01165-
dc.identifier.isi000469432700001-
item.fulltextWith Fulltext-
item.contributorHOUBEN, Evelien-
item.contributorHELLINGS, Niels-
item.contributorBROUX, Bieke-
item.accessRightsOpen Access-
item.fullcitationHOUBEN, Evelien; HELLINGS, Niels & BROUX, Bieke (2019) Oncostatin M, an Underestimated Player in the Central Nervous System. In: FRONTIERS IN IMMUNOLOGY, 10 (Art N° 1165).-
item.validationecoom 2020-
crisitem.journal.issn1664-3224-
crisitem.journal.eissn1664-3224-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
houben 1.pdfPublished version1.13 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

2
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

32
checked on Apr 22, 2024

Page view(s)

50
checked on Jul 15, 2022

Download(s)

6
checked on Jul 15, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.